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Expression of the extensive arsenal of virulence factors by Streptococcus pyogenes is controlled
by many regulators, of which CovRS is one of the best characterized and can influence ~15% of
the genome. Animal models have established that mutants of covRS arise spontaneously in vivo
resulting in highly invasive organisms. We analysed a pharyngeal and a blood isolate of
S. pyogenes recovered from the same individual 13 days apart. The two isolates varied in many
phenotypic properties including SpeB production, which were reflected in transcriptomic
analyses. PFGE, multilocus sequence typing and partial sequencing of some key genes failed to
show any differences except for an 11 bp insert in the covS gene in the blood isolate which
caused a premature termination of transcription. Complementation of a fully functional covS gene
into the blood isolate resulted in high expression of CovS and expression of speB. These results,
showing a pharyngeal and a blood isolate from a single individual differing by a simple insertion,
provide evidence for the model that regulatory gene mutations allow S. pyogenes to invade
different niches in the body.
INTRODUCTION
Streptococcus pyogenes (a group A streptococcus; GAS) is a
globally distributed pathogen capable of producing a broad
spectrum of diseases (Cunningham, 2000, 2008; Musser &
DeLeo, 2005; Tart et al., 2007). Two sites of primary
infection are pharyngeal cells of the throat and the
epidermis of the skin, which usually result in the self-
limiting disease of pharyngitis and impetigo, respectively.
For some GAS infections, however, more severe, life
threatening diseases such as septicaemia, toxic shock
syndrome and necrotizing fasciitis may ensue. Both
variations in host responses and the differential expression
of the wide arsenal of virulence factors contribute to the
different disease outcomes of GAS infections.
Expression of virulence genes is controlled by about 100
stand-alone and at least 13 two-component regulators
(Graham et al., 2002; Nagamune et al., 2005). CovRS is the
best characterized two-component regulator (Churchward,
2007). Initially described as regulating hyaluronic acid
capsule synthesis (Levin & Wessels, 1998), its ability to
control multiple virulence genes became appreciated
shortly after its identification (Federle et al., 1999). In
fact, the CovRS regulon is responsible for controlling
~15% of the GAS genome, including many of the major
virulence factors involved with adhesion to host tissues,
evasion of the immune system and enzymes that may
promote the spread of the bacteria (Graham et al., 2002).
Unusual features of the CovRS system include the ability of
CovR to repress rather than activate gene expression and to
respond to both external environmental and internal
metabolic signals (Churchward, 2007).
Most studies evaluating the effect of CovRS on GAS
pathogenesis have relied on mouse models. covR mutants
increased the transcription of virulence factors compared
with their isogenic wild-type, resulting in necrotizing
lesions in mice (Heath et al., 1999). In mouse models of
skin infections, Ravins et al. (2000) noted that a colony of
GAS could switch consistently and irreversibly from a
poorly encapsulated colony to a highly mucoid one and
that the conversion could be mimicked by changes in
Abbreviations: FBS, fetal bovine serum; GAS, group A streptococci;
MLST, multilocus sequence typing; qRT-PCR, quantitative RT-PCR; THY,
Todd–Hewitt broth supplemented with 0.1% yeast extract.
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The NCBI Gene Expression Omnibus (GEO) series accession number
for the microarray data in this publication is GSE21316 (available at
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21316).
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Gene (size; bp) Forward sequence (5§–3§) Reverse sequence (5§–3§)
speB* (1197)
Set 1 GTGCCTCAGGTTCTGTTCTAACG CAGCTACAGGATGTGTTGCTACTG
Set 2 TAGTCTTTCAACCCTTTGTTAGGG GTAAGGAGGTGTGTCCAATCTACC
ropB* (843)
Set 1 CCAAATCAAAAAGCTAACACCA TTGAACCTCGATAAATACAATACCC
Set 2 AATCGATTCATTCCCATAATATCT TGTCAATGTTGATGAGTTTCTCTTT
Set 3 CCTTCTATGTTTCGGCATTCA ACACACGTAACGTATTTTTAACATCT
ropB–speB intergenic region* (940)
Set 1 CAACGGTTTCACCAATTTCC TCGTGATAGGTCCACAACA
Set 2 TCAGCCAGGAAAAAGCCTAC TCGGCAAATTACTGGGTTAGC
covRD (687)
Set 1 TTTGACCATAGAGGGCAGAGA CGGGCAAGTAGTTCTTCAATG
Set 2 GGGTCGTGAAGGGTTAGAAACTG GCCGCGGAGATAACGAATATAG
Set 3 CCCGTATTCGTGCTATTTTCC AGGCAATCAGTGTAAAGGCAGAG
covSD (1503)
Set 1 GAAGCCGTTGAGACTAATGTTG CCCACGATACCTGATCTTCGATATG
Set 2 GCAGTCGAGTCATTAGGAGTGAG GCAACCGGTGTTCGTAATTC
Set 3 GGCGCTTTTTGAAGCCTTTAC CGGGAATACTTCACAGCATTG
Set 4 GATTCGCGTACAAGGCTCAT CAGTTGTGGCAAAAGACTGC
sagA/pelD (162) GAGCTAGCCTTGTCCTTGTTGT TGCTAGCAAACTCATTACCC
nraD (1536)
Set 1 GCACATACAACAGAATCAGG GCACATACAACAGAATCAGG
Set 2 CTGTATACCTCGGCAAGGAAAAAG CAATTGTCGGAGAGGAATATCG
Set 3 GGCGATGTTCTTAAATGG TTGTTTTGTCAAACCTGTTAAGGA
Set 4 TCAGAGGTTGTGATGATGTTCC GTCATTTGGGGTCCTTCTTTCT
dppAD (1629)
Set 1 AGCCCTGAGTATCTTCCTGA GGGATTTCAGTCAACTGTGCTG
Set 2 GTGAGCCTGTTACTGCTGACGA TTGCTGGATCGCTAGTGACATC
Set 3 TGATCTACGCGACACCAGAACT CTGCTAGGCTTGGATGATGTGA
Set 4 CAGAGCAAGCCAAAGCCCTA AAAGGAGCCGAGGAAACGAT
dppB–ED (3117)
Set 1 CCTCGGCTCCTTTTCTTATCG GCTGGTACGATAGCATTTCTAAGG
Set 2 CGTTAGCTGATCGGATTAAGCA TAGACCTGCAAGCACTCCAAAA
Set 3 CTTTACGCAACCTCGCTCCTT TGAGTGAAGGTGATGGAGAGGTC
Set 4 CCTTTCTGCCGAACAACCTT GTGGGCTCATCCGCAATAAT
Set 5 GTCAAACATCAGGTGCGCTTAG GGTTTGTTCAGGATGTTGTTGG
Set 6 AGCACCTGGTCAAATCTTAGGG GGCAAAGAACTTGCAGACGA
oppAD (1971)
Set 1 CGCTACCATGAGAGAATGACAA GGGCTTTGACACCAACTTCTTT
Set 2 TTTGACTAATGGCGGTGGAAC GGGTCTGAACCATCTGAACCAT
Set 3 GAACAAGCCTGAAAGCTACTGG CGCTCGGTCAAAAGCAAACT
Set 4 AGACCCTGCACAACAAGATGC GGTCTCAGCATAGAAGCCTTGG
Set 5 GAAGCTTTGACAGCTGAAGG CGGCTTTAGTAACTCGTGGAGTG
Set 6 CCAAGATCCACGGACCTACC ACGATCGCATGATACGGTTT
oppBD (4425)
Set 1 TCAAGACAAACCTGTCACAGCA ATCCTGAATCTTCCAAGGGTGA
Set 2 GTAGTGTAACGACAGAAGCAAC ACCAAGAGGCAAACCAACGATA
Set 3 ACAAGGGCAAGGACGAACAG CTGGCCTGAAGGTCAACAAGAT
Set 4 GTTTCTCAACAGCGACCATGAC CTTCACTATCGCGCTCAACAAA
Set 5 TGGTGGTGCAACCTTAACAGAG GGCTCCTAAACACTACCCCAATG
Set 6 TCCAATGTTTGCCAACTACGAC GGTTGGTAAACCAATCCCAAAG
Set 7 GCCTACTCCATCCGTGTTCAA AGCCTGATTCCCCTACAAAAGC
Set 8 CCACTGACCCACGTTCACATAG AGGGCTGTTGTTGGCTCATC
Set 9 CGGTAGCCAAATCACAGAAGTG CCTCTGGGTGTAAAAGCCATGT
Set 10 CAGTTGGCAGATGAATCTGGTG AAACTAGCAGCGGGATCTTGG
Set 11 AGTTGGAGAATCTGGGAGTGGT TGGATAACCGCAATACGATCTG
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3086 Microbiology 156CovRS. Engleberg et al. (2001) showed that rare sponta-
neous and more virulent mutants of covRS could be
generated by infecting mouse skins. In an elegant study
using microarray analyses, Sumby et al. (2006) identified
pharyngeal and invasive transcriptome profiles in human
M1 isolates. After subcutaneous injection with a mouse-
passaged pharyngeal M1 strain, they found isolates
recovered from deep tissue had converted to an invasive
transcriptome by an insertion of 7 bp into the covS gene.
Such a loss of covS gene expression resulted in the shut-off
of SpeB production, which in turn allowed the accumula-
tion of plasmin, triggering systemic spread of the organism
(Cole et al., 2006).
In this report, we identify a pharyngeal isolate and a blood
isolate of S. pyogenes isolated 13 days apart from a single
individual that were genetically similar except for an 11 bp
insert into the covS gene leading to a covS truncated
mutant. The presence of two isolates that differ in the covS
gene may have resulted in the invasion of S. pyogenes into
the blood. Such insertions have been well documented in
mouse models, but to our knowledge, this is the first report
suggesting that a pharyngeal isolate may have converted
into an invasive blood isolate by a covS insertion in the
same individual.
METHODS
Bacterial strains/clinical isolates. The recovered isolates were part
of a current epidemiological study of GAS in Hawai‘i hospitals
approved by theInstitutional ReviewBoards(Erdem et al., 2005, 2009).
GAS isolates were obtained from a single patient at Kapi‘olani Medical
Center on O‘ahu at two different times. The initial isolate (UH322) was
from a 9-year-old male who was diagnosed with pharyngitis. After
culturing S. pyogenes, he was prescribed penicillin for 10 days but was
compliant for only 5 days. On day13, he wasbroughtto the emergency
room after reporting feeling ill for a few days with insect bites and right
inguinallymphadenopathy.Thepatientwasplacedonclindamycinand
his blood culture revealed S. pyogenes (UH328) identified using
standard methodology. A single colony from the pharyngeal culture
recovered earlier and a single colony from the blood culture were
inoculated into Todd–Hewitt broth (Difco) supplemented with 0.1%
yeast extract (THY) (Difco) and grown overnight (~20 h) at 37 uC
with 5% CO2. Glycerol was added to a final concentration of 15% and
aliquots were frozen at 280 uC (Erdem et al., 2009). All subsequent
studies used these stock cultures.
DNA isolation, PCR and sequencing. DNA was prepared using the
genomic wizard purification kit (Promega) following the manufac-
turer’s instructions. Isolated DNA was used immediately or stored at
220 uC. PCRs were performed by using either published primer
sequences or primers designedusing Primer3 (http://frodo.wi.mit.edu;
Table 1) and standard protocols. Other primers used included those
for speB, sda, rgg, mga and sagA/pel genes from the paper by Virtaneva
Table 1. cont.
Gene (size; bp) Forward sequence (5§–3§) Reverse sequence (5§–3§)
Set 12 CTGATGAGCCGATTTCAGCTTT CGGCTAAATTGACTCGTTCTACC
*Primers designed using the M1 genome (NC_002737).
DPrimers designed using the M3 genome (NC_004070).
Fig. 1. PFGE patterns of the pharyngeal (UH322) and blood (UH328) isolates. (a) PFGE of SmaI-digested DNA of UH322
(lane 1) and UH328 (lane 2). (b) PFGE of SfiI-, ApaI-, SgrAI- and SacII-digested DNA of UH322 (lanes 1–4) and UH328 (lanes
5–8). Molecular mass marker (MW) is lambda concatameric DNA marker.
CovS differences in two GAS isolates
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Exo-SAP (US Bioscience) and heated. The forward or reverse primer
(4 pg ml
21) was added and submitted to the University of Hawai‘i
biotechnology facility.
PFGE and multi-locus sequence typing (MLST). Isolated DNA
digested with SmaI, SfiI, ApaI, SgrAo rSacII (New England BioLabs)
was analysed by PFGE as described by Svensson et al. (2000). For
MLST, the sevenhousekeepinggenes (gki, gtr, murI, mutS, recP, xpt and
yqiL) wereanalysed byPCRusingtheprimersandconditions described
on the MLST database (http://spyogenes.mlst.net/misc/info.asp).
Growth kinetics. Single colonies from blood agar plates were
inoculated into THY until stationary phase was reached. One millilitre
of culture at OD600 1.0 (Biomate 3 spectrophotometer; Thermo
Electron Corporation) was added to 150 ml THY. Two millilitres of
each culture was removed at the indicated times to measure OD600.
Adhesion and invasion assays. Assays were adapted from the
method of Hagman et al. (1999). Hep-2 cells (3.8610
5 cells per well) in
RPMI 1640, 2 mM glutamine and 10% fetal bovine serum (FBS) were
seeded into 24-well plates (Costar) on the day prior to the assay. Bacteria
were grown to log or stationary phase in THY, harvested by
centrifugation, washed twice, resuspended in RPMI containing 1% FBS
and sonicated for 30 s to disrupt chains. After adjusting the bacteria to
1610
8 bacteria ml
21 based on OD600, 1 ml was added to triplicate wells,
centrifuged for 10 min at 125 g to accelerate contact and washed three
times with PBS before adding 500 ml 0.025% Triton X to the wells.
Bacterial counts were determined by serial dilution and plating on THY
agar. Per cent adherence was calculated by dividing the number of bacteria
recovered in each well by the starting inoculum and multiplying by 100.
A similar procedure was used for invasion except that after
centrifugation to promote contact, the cultures were incubated
further for between 30 and 120 min, at which time the medium was
removed, the cultures were washed twice and 400 mg gentamicin
sulfate ml
21 (Mediatech) in PBS was added. Samples were incubated
for 30 min to kill the extracellular bacteria and washed four times
before adding 500 ml 0.025% Triton X in PBS. Per cent internaliza-
tion was calculated by dividing the number of bacteria recovered in
each well by the starting inoculum and multiplying by 100.
SpeB assays. Bacterial supernatants were collected every 3 h during
growth kinetic experiments as described above. The supernatants were
clarified by centrifugation, split into aliquots and stored frozen at 270 uC
until tested. SpeB activity was determined according to the methods
Fig. 2. Phenotypic differences between the pharyngeal and blood isolates. (a) Bacterial growth of UH322 (X) and UH328 (h)
strains was monitored by recording the OD600 at various intervals over a 24 h period. The result of a single representative
experiment is presented. (b) Haemolysis of UH322 and UH328 isolates on enhanced blood agar plates. The diameter of b-
haemolysis surrounding the UH322 isolates measured 0.5 cm (left), whereas the diameter for UH328 isolates measured
approximately 0.35 cm (right). Photos were taken under transillumination. Bar, 1 cm. (c) Adherence of stationary and
exponential phase cultures of UH322 and UH328 isolates. The bacteria were added to triplicate wells seeded with Hep-2 cells.
The per cent adherence was determined by calculating the c.f.u. that adhered to Hep-2 cells divided by the c.f.u. in the original
inoculum, and multiplying by 100. The adherence represents mean±SD of three experiments. (d) Internalization of UH322 and
UH328 during stationary and exponential phase cultures. Bacteria were grown to stationary or exponential phase and each was
added to triplicate wells of Hep-2 cells, allowed to internalize for 2 h and treated with antibiotics to kill external bacteria. Per
cent internalization was determined by dividing the amount of bacteria recovered from lysates of each well by the starting
inoculum and multiplying by 100. Values represent the mean±SD of two experiments.
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protease activity, 100 mM trans-epoxysuccinyl-L-leucylamido(4-guani-
dino)-butane (E64) (Sigma Aldrich) was added to the culture super-
natants to a final concentration of 1 mM before adding the substrate.
For immunoblot assays, SpeB culture supernatants were separated by
electrophoresis on a 12% SDS-PAGE gel and transferred to Biodyne B
Membrane (KPL) according to the method by Sambrook et al. (1989).
Membranes were incubated with appropriately diluted monoclonal
rabbitanti-SpeBIgG (ToxinTechnologies),goatanti-rabbitconjugated
to alkaline phosphatase and alkaline phosphatase substrate according
to the manufacturer’s instructions (Bio-Rad Laboratories).
RNA isolation. RNA was isolated from early stationary phase
cultures (OD600 0.7–1.0) according to the method of Froeliger &
Fives-Taylor (1998) with some modifications. Cultures were cen-
trifuged at 6000 g (Jouan) for 10 min and washed. Total RNA was
extracted by vortexing with acid-washed glass beads (Sigma Aldrich)
and by adding phenol/chloroform/isoamyl alcohol (25:125:1; Fisher
Biotech) and 10% SDS. RNA was precipitated with 10 M lithium
chloride and 100% isopropyl alcohol (Fisher Scientific), treated with
DNase (Ambion), quantified on Agilent 2100 Bioanalyser (Agilent
Technologies) and stored at 280 uC. TaqMan PCR assays of the
streptokinase (ska) gene were performed with RNA templates to
ensure absence of contaminating genomic DNA.
Microarray. Total RNA from early stationary phases between the two
isolates were compared using custom Nimblegen Systems microarray
chips. Total RNA, at 1.0 mg ml
21 in nuclease-free water, was sent to
Nimblegen for labelling, hybridization and detection. The RNA
samples were labelled and hybridized onto two separate custom-made
microarray chips containing probes for five different fully sequenced
S. pyogenes genomes replicated twice [M1 GAS (NC_002737),
MGAS10394 (NC_006086), MGAS315 (NC_004070), MGAS8232
(NC_003485) and SSI-1 (NC_004606)]. Microarray analysis was done
using GeneSpring 7.0 (Agilent Technologies) on normalized Nimblegen
data. Microarray data were filtered on greater than twofold expression
andaPvalueof¢0.05. Thedatadiscussedinthispublicationhavebeen
deposited in NCBI’s Gene Expression Omnibus (GEO) and are
accessible through GEO series accession number GSE21316 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21316).
Quantitative RT-PCR (qRT-PCR). Single-stranded cDNA was
synthesized using Superscript III (Invitrogen) according to the
manufacturer’s instructions using SYBR green Supermix on an
iCycler (both Bio-Rad Laboratories). The cycling parameters for qRT-
PCR were 95 uC for 15 s, 55 uC for 30 s and 72 uC for 30 s using
either published PCR primers (Virtaneva et al., 2003) (Table 1). All
samples were tested in triplicate for each run.
Complementation of a functional covS gene in UH328. The covS
complementation plasmid pJRS325 in Escherichia coli Top 10 cells
was provided by Dr June Scott (Dalton & Scott, 2004). The plasmid
was purified by caesium choloride/ethidium bromide centrifuga-
tion according to methods described by Sambrook et al. (1989).
Electroporations were done following the method of Simon &
Ferretti (1991) with a few modifications. THY broth (20 ml) was
inoculated with 0.4 ml of an overnight culture of S. pyogenes and
grown at 37 uCf o r3ht oO D 600 0.2 (4610
8 c.f.u. ml
21). Cells were
harvested by centrifugation and resuspended in 1 ml ice-cold sterile
0.5 M sucrose. Cells were washed with 0.5 M sucrose and pelleted.
The cells were then resuspended in 100 ml 0.5 M sucrose, and 1 mg
plasmid DNA was mixed with 40 ml cell suspension and transferred
to a chilled Gene Pulser cuvette (0.2 electrode gap; Bio-Rad) and
exposed to one electric pulse with the Bio-Rad Gene Pulser (peak
voltage 2.5 kV; capacitance 25 F; pulse controller 200 V). After the
electric pulse, the cells were immediately diluted in 1 ml THY and
incubated for 2 h at 37 uC to allow for expression; cells were plated
on THY agar containing 0.5 mg erythromycin ml
21 and grown
overnight. A colony was selected, reisolated and used for further
studies.
RESULTS
Identical emm sequences, PFGE patterns and
MLST
The pharyngeal (UH322) and blood (UH328) isolates were
typed as emm 81.0 and had identical sequences over 450
contiguous nucleotides including the first 240 nt. Both
isolates shared the same T pattern, 8/B3264, and both were
opacity-factor-positive (data not shown). To expand the
genetic analysis, PFGE was performed on both isolates
using SmaI (Fig. 1a) and four other restriction enzymes:
SfiI, ApaI, SgrAI and SacII (Fig. 1b). The pharyngeal and
blood isolates gave identical banding patterns. MLST
analysis revealed identical alleles at all seven loci for both
isolates. The alleles for loci gki, gtr, murI, mutS, recP, xpt
and yqiL were 38, 2, 60, 23, 39 and 2, respectively, giving a
profile sequence type 330.
Fig. 3. Functional activity and Western blot analysis. (a) SpeB
activity of UH322 and UH328 isolates. Culture supernatants were
collected at the indicated times and stored frozen until testing by
adding activation buffer and substrates. A405 was read to
determine substrate cleavage. Results from a single representative
experiment are shown. (b, c) Overnight culture supernatants of
UH322 and UH328 were resolved on a 12% SDS-PAGE gel and
transferred to nitrocellulose membranes. The membranes were
probed using rabbit anti-SpeB and anti-Streptolysin-O (SLO),
respectively. Bound antibodies were reacted with goat anti-rabbit
conjugated to alkaline phosphatase and visualized with alkaline
phosphatase substrate.
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and blood isolates
Growth kinetics showed that the pharyngeal isolate grew
faster and to a higher density than the blood isolate (Fig.
2a). On enhanced blood agar plates (Fig. 2b), the zone of
b-haemolysis was larger around UH322 (diameter 0.5 cm)
than UH328 (diameter 0.35 cm). These phenotypic
differences between the pharyngeal and blood colonies
remained stable after multiple in vitro passages. For the
pharyngeal (UH322) isolate, adherence and internalization
on Hep-2 cells were greater during the exponential phase,
whereas for the blood (UH328) isolate, the stationary phase
bacteria adhered and internalized better to Hep-2 cells than
the exponential phase cells (Fig. 2c, d).
T h em o s tn o t a b l ep h e n o t y p i cd i f f e r e n c ew a st h ep r o d u c t i o n
of SpeB by the pharyngeal isolate but not by the blood isolate.
SpeB activity peaked for the pharyngeal isolate during late-
exponentialphase,whereasSpeBactivitywasnotfoundinany
of the culture supernatants from the blood isolate (Fig. 3a).
Inclusion of 1 mM E64, a cysteine protease inhibitor, abolished
SpeB activity of the pharyngeal isolate. Immunoblot of
overnight culture supernatants from the pharyngeal and the
A. F. Garcia and others
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pharyngeal isolate and not by the blood isolate (Fig. 3b)
whereas streptolysin O was secr e t e do n l yb yt h eb l o o di s o l a t e
(Fig. 3c).
Transcription analysis comparing the pharyngeal
and the blood isolate
The transcripts that were upregulated in the blood isolate
compared with the pharyngeal isolate were determined
Fig. 4. Transcriptome profile analysis of pharyngeal and blood isolates. Microarrays were done on two separate microarray
chips. Expression profiles to five GAS genomes were assessed: NC_002737 (M1), NC_003485 (M18), NC_004070 (M3),
NC_006086 (M6) and NC_004606 (M3; not shown). Genes differing in expression by twofold and with a P value ¢0.05
between pharyngeal and blood isolates are depicted. Fold transcript differences between the pharyngeal and blood isolates for
all known virulence genes and gene regulators are shown. Genes that were expressed at higher levels in the blood isolates are
shown above 1.0; genes that were expressed at higher levels in the pharyngeal isolates are shown below 1.0.
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expressed by twofold with a P value ,0.05. The number
of transcripts that differed between UH322 and UH328
depended on the origin of the probe sets. Comparing the
blood isolate relative to the pharyngeal isolate, probes
generated from NC002737 (M1) resulted in 92 upregulated
transcripts (of which 42 were identified) and 23 down-
regulated transcripts (10 named); probes generated from
NC003485 (M18) showed 85 upregulated transcripts (28
named) and 36 downregulated transcripts (9 named);
probes from NC004070 (M3) gave 79 upregulated
transcripts (36 named) and 32 downregulated transcripts
(16 named); and from NC006086 (M6) gave 69 upregu-
lated transcripts (55 named) and 40 downregulated
transcripts (30 named). Probes generated from
NC004606, another M3 strain, hybridized poorly to the
cDNA from our emm 81.0 isolates and were not analysed
further. Those genes differing in expression between
pharyngeal and blood isolates are depicted in Fig. 4(a–d)
(hypothetical genes and those identified with broad
functional categories were removed). Transcripts found
predominantly in the pharyngeal isolate included speB,
mitogenic factor and streptolysin-S-associated genes.
Notable transcripts upregulated in the blood isolate were
hasA, which encodes an enzyme responsible for hyaluronate
capsule formation, to genes involved with sugar metabolism
or phosphorylation of sugars, and sagP, a gene known as an
anti-tumour protein but which possibly has arginine
deaminase activity. The nomenclature of genes found in
NC006086 differed dramatically from the other S. pyogenes
strains, so comparisons were difficult; however, using this
probe set, streptodornase (sda1) was prominent in the
pharyngealisolate, a geneencoded by a prophage that willbe
discussed below.
qRT-PCR using total RNA from early stationary phase
confirmed the differential expression of the pharyngeal and
the blood isolates. We focused on the positive gene
regulators ropB, mga and sagA and the negative gene
regulator covR, known to affect SpeB production, by qRT-
PCR. As controls, two virulence factor genes, speB and sda,
and two standards, emm and proS, were tested. The most
dramatic difference between the blood and pharyngeal
isolates was found in the speB transcript: a blood to
pharyngeal ratio of 0.04 was found. sda gave a ratio of 0.13
whereas the positive regulators ropB, sagA and mga gave
ratios of 0.20, 0.27 and 1.1, respectively. covR showed a low
but significant reduction in the blood isolate yielding a
ratio of 0.67; at this point, we did not evaluate covS. Both
emm and proS yielded a ratio of 1.0.
Sequence analysis of selected genes revealed an
11 bp insertion in the blood isolate
We sequenced both stand-alone and two-component
regulatory genes that have been identified as affecting speB
expression (Nagamune et al., 2005). The sequences of the
positive regulators dppA, B, C and E, mga, oppA, B, C, D and
F, RopB, sagA/pel were identical in the pharyngeal (UH322)
and blood (UH328) isolates (primers given in Table 1). The
possibility that speB (1194 nt) and its intergenic promoter
region (940 nt) might differ between the two isolates was
tested, but the sequence of this gene in the two isolates was
identical. The covR sequences of the two isolates were
identical, but an 11 bp insert in covS was found in the blood
isolate that was absent in the pharyngeal isolate (Fig. 5). This
insert was found using two different primer sets for the covS
gene, after decreasing the cycle number from 30 to 20, and
after using high fidelity Taq polymerase. The insert was
present in stock colonies produced directly from the blood
agar plate obtained from the clinical laboratory and in
colonies passed many times. The 11 bp insertion at nt 103 in
the covS gene resulted in a stop codon in the covS open
reading frame, causing a deduced truncated CovS polypep-
tide of 39 aa from the CovS methionine start codon. The
insert was not found in four other emm 81.0 isolates (three
blood isolates and one from a deep tissue wound) in our
collection (data not shown).
Complementation of functional covS into UH328
qRT-PCR of UH322, UH328 complemented with pJRS325
and UH328 was done using RNA isolated from bacteria
grown to early (8 h) and late (12 h) stationary phase (Fig.
6a, b). The insertion of a functional covS complemented
UH328 and this strain expressed high amounts of CovS
that greatly exceeded that of UH322. However, the general
profile of the expressed genes tested by qRT-PCR paralleled
that of UH322.
DISCUSSION
We have shown that a pharyngeal (UH322) and a blood
(UH328) isolate obtained from the same patient 13 days
apart were phenotypically diverse but genetically similar,
except that the blood isolate had an insertion of 11 bp in its
covS gene. This insertion resulted in a stop codon and a
truncated deduced CovS peptide of 39 aa. Among the
phenotypic differences between the two isolates, the most
noteworthy was the loss of SpeB production, but these also
included adherence and internalization characteristics,
haemolysis pattern and their growth curve kinetics, features
similar to covR/S deletion mutants. The microarray data
provided evidence that the pharyngeal isolate gave a pattern
similar to the M1 pharyngeal transcriptome pattern and the
blood isolate gave a profile similar to the invasive
transcriptome profile identified by Sumby et al. (2006),
most prominent of which was the increase of the speB
transcript in the pharyngeal isolate and the decrease in the
has gene transcript relative to the blood isolate. These two
transcripts could be identified regardless of the probe origin.
Genetic analysis established close DNA similarity between
the UH322 and UH328 by PFGE and MLST analyses as well
as identifying that several regulator genes had identical
sequences (Table 1) except for the insertion in the covS gene.
A. F. Garcia and others
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of the pharyngeal isolate into the blood isolate. The most
compelling circumstantial evidence is the similarity of our
findings to those studies performed in animal models. In a
mouse model of skin infections, Ravins et al. (2000)
reported that a colony of M6 GAS could switch irreversibly
to a more mucoid one and that the switch could be
duplicated by mutations in covR/S. Spontaneous mutants
of covR/S from experimental mouse skin infections
(Engleberg et al., 2001) showed that covR mutations were
due to single amino acid substitutions, whereas most of the
covS changes were due to frameshift or sense mutations.
The covS mutation reported in our work resulted in a
frame shift and insertion of a stop codon. Sumby et al.
(2006) established that after subcutaneous injection with a
mouse-passaged pharyngeal M1 strain, isolates could be
recovered from internal organs that had converted from a
pharyngeal to an invasive transcriptome due to a 7 bp
insert into the covS gene.
It is possible that our blood isolate did not derive directly
from the pharyngeal isolate, since our patient could have
either possessed more than one emm 81.0 isolate initially or
encountered another emm 81.0 isolate shortly after initial
infection. The fact that skin lesions were observed on the
child upon his second visit might indicate that the skin
infection could have been another source of GAS.
However, cultures were not taken from the skin and even
if proven to be emm 81.0 GAS, they could have been a
result of self-infection from the original pharyngeal isolate.
We recognize the fact that both PFGE and MLST lack
sensitivity for closely related isolates compared with SNP
analysis or comparative genomic sequencing (Beres et al.,
2006). Complete genome sequencing of UH322 and
UH328 may provide direct evidence that the pharyngeal
isolate converted to the blood isolate if the two genomes
prove to differ only in the 11 bp insert. However, the blood
isolate may have undergone additional mutations that led
to multiple differences between the pharyngeal and blood
isolates. We inserted a functional covS gene into UH328
which resulted in an overexpression of CovS relative to
UH322. The expression of speB, sagA, rgg/ropB, dpp, emm
and sda in UH328 paralleled that of UH322. In future
experiments, we hope to inactivate the covS gene in UH322
to determine if the transcriptomic profile switches to that
obtained with UH328. Recently, it has been reported that
DNase Sda1, a phage-encoded virulence factor, serves as a
selective force for covRS mutation (Walker et al., 2007).
The pharyngeal isolate mimics the M1 isolate studied by
Walker et al. (2007), in that it appears to contain the
Fig. 5. Nucleic acid sequence alignment of UH322 and UH328 for the covS gene. The nucleotide sequence is shown for
UH322 (top line) and UH328 (lower line) starting from the 59 end. An asterisk indicates an identical nucleotide in UH322 and
UH328. Insertion of the 11 bp at nt 103 for UH328 is represented in bold letters. Insertion of the 11 bp sequence at position
103 in UH328 results in a truncated polypeptide of 39 aa. Underlined letters in UH322 indicate the stop codon for UH328.
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means the bacteria have a selective advantage. The fact that
the patient did not fully comply with the antibiotic
treatment and returned to the hospital 13 days later gives
temporal evidence that the pharyngeal isolate could have
mutated to become systemic. Perhaps infecting cynomol-
gus macaques, shown to be a good model for GAS
pharyngitis (Virtaneva et al., 2003, 2005), and subjecting
them to partial antibiotic treatment will clarify whether or
not the lack of compliance was a contributing selective
pressure for the pharyngeal isolate to enter the blood.
Definitive proof that the pharyngeal isolate changed to a
blood isolate cannot be easily established with humans. The
finding of our two isolates depended on a serendipitous
sequence of events that may have included partial
compliance with antibiotic therapy. Regardless of the
ultimate conclusions based on future studies, the iden-
tification of two genetically similar but phenotypically
different emm 81.0 isolates in a single patient gives
credence to the model of GAS invasiveness that has been
proposed based on animal experimentation (Sumby et al.,
2006; Tart et al., 2007; Virtaneva et al., 2003). The animal
model shows that GAS can acquire mutations that allow it
to escape one niche and enter another that greatly enhances
its virulence potential. We hope that future characteriza-
tion of these two isolates will show that they differ only in
the 11 bp insert, thereby more firmly establishing that this
model of invasiveness occurs in humans.
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